Increased intrahepatic apoptosis but reduced immune activation in HIV-HBV co-infected patients with advanced immunosuppression
David M Iser, Anchalee Avihingsanon, Naruemon Wisedopas, Alexander J Thompson, Alison Boyd, Gail V Matthews, Stephen A Locarnini, John Slavin, Paul V Desmond, Sharon R Lewin
AIDS | LIPPINCOTT WILLIAMS & WILKINS | Published : 2011
The work was supported by the National Health and Medical Research Council (NHMRC) of Australia. S. R. L. is supported by an NHMRC Practitioner Fellowship. D. I. and A. T. are recipients of an NHMRC postgraduate scholarship. T.N. has received support from the Gastroenterological Society of Australia (GESA).Tenofovir in Co-infection (TICO) study was supported by Gilead Sciences. Clinical trial number NCT00192595.S.A.L. is a consultant for, advises, and received grants from, Evivar Pty Ltd and Gilead. He is a consultant for and owns stocks in Pharmasset, is a consultant for Bristol-Myers Squibb and has consulted for Abbott Laboratories. S. R. L. advises and has received grants from Gilead.